• Raised approximately $47 million from the Retail Entitlement Offer
• Received applications for ~31 million New Shares, representing a 40% take-up rate
• Eligible retail shareholders who applied for additional New Shares will have their application allotted in full

PYC Therapeutics Limited (ASX:PYC) has completed the retail component of its pro rata accelerated non-renounceable entitlement offer (Retail Entitlement Offer) of new fully paid ordinary shares (New Shares). The Retail Entitlement Offer closed on Friday 27 February 2026 and raised approximately $47 million at an offer price of $1.50 per New Share. PYC received applications for ~31 million New Shares, including additional New Shares applied for up to an additional 100% of their entitlement, representing a take-up rate of 40%. The Company confirms that eligible retail shareholders who applied for additional New Shares up to an additional 100% of their entitlement will have their application allotted in full. The New Shares under the Retail Entitlement Offer are expected to be issued on Friday 6 March 2026 and commence trading on the ASX on Monday 9 March 2026. Of the remaining approximately 46 million New Shares not taken up under the Retail Entitlement Offer, ~11 million New Shares will be issued to underwriters pursuant to the underwriting agreement. PYC reserves the right to place the remaining ~35 million New Shares not taken up under the Retail Entitlement Offer or by the Underwriters within the 3-month period following the close of the Retail Entitlement Offer.